Tickers

1. Composite Trajectory Verdict

For a capital-intensive broadband provider like CABO, the cash flow statement carries the most weight because the business model relies on converting Adjusted EBITDA into discretionary free cash flow after heavy maintenance capex, debt service, and now a large acquisition commitment; the income statement is distorted by large non-cash impairments and equity-method losses, while the balance sheet primarily reflects the cumulative effect of those non-cash charges and financing decisions.

Composite Trajectory: Deteriorating

All three statement-level assessments point downward. Annual revenue has fallen for two consecutive years (2023: $1.68B → 2024: $1.58B → 2025: $1.50B). Annual operating cash flow dropped 15% in 2025 to $563M after two flat years near $664M. Stockholders' equity collapsed 77% in the first half of 2026 alone (from $1.43B at year-end 2025 to $326M at June 30, 2026) due to a second massive impairment wave and MBI-related fair-value losses. Adjusted EBITDA (non-GAAP) declined 6.1% for full-year 2025 and 12-15% year-over-year in the first half of 2026. No offsetting improving trend appears in any GAAP metric across the three statements.

2. Red Flags

• Recurring multi-hundred-million-dollar impairments: $586.0M in Q2 2025 (franchise agreements $497.2M + goodwill $88.8M) and $597.7M in Q2 2026 (franchise agreements $526.0M + goodwill $71.7M) (10-K 2025-12-31, Critical Accounting Policies; 10-Q 2026-06-30, Critical Accounting Policies).
• Equity evaporation: Stockholders' equity fell from $1,433.6M at 2025-12-31 to $326.4M at 2026-06-30, a 77% decline in six months (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
• MBI fair-value and equity-method losses: Q2 2026 other expense included a $444.0M non-cash loss on the MBI option fair-value adjustment and equity-method loss included a $349.8M impairment of the MBI investment (10-Q 2026-06-30, MD&A Other Income/Expense and Equity Method Investment).
• Revolver draw to repay maturing convertibles: $575M borrowed on the Revolving Credit Facility in H1 2026 to repay the 2026 Notes in full, increasing long-term debt from $2,600.4M to $3,027.1M (10-Q 2026-06-30, Financing Activity).
• MBI Put Option liability on balance sheet: $426.0M current liability recorded at 2026-06-30 for the Put Option exercised Jan 2, 2026, with estimated $480M put price plus ~$920M of MBI term loans to be assumed at closing (10-Q 2026-06-30, Condensed Consolidated Balance Sheets; Liquidity).
• Residential data subscriber losses accelerating: Residential data PSUs fell 5.8% YoY at 2025-12-31 (899.7K vs 955.0K) and 6.6% YoY at 2026-06-30 (870.0K vs 932.0K) (10-K 2025-12-31, PSU and Customer Counts; 10-Q 2026-06-30, PSU and Customer Counts).
• Adjusted EBITDA declining in both annual and interim periods: Full-year 2025 Adjusted EBITDA $801.7M vs $854.0M in 2024 (-6.1%); H1 2026 $356.8M vs $405.9M in H1 2025 (-12.1%) (10-K 2025-12-31, Use of Adjusted EBITDA; 10-Q 2026-06-30, Use of Adjusted EBITDA).
• Operating cash flow declining: FY 2025 $563.3M vs FY 2024 $664.1M (-15.2%); H1 2026 $239.1M vs H1 2025 $261.3M (-8.5%) (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows).
• Dividend suspended: Quarterly cash dividend suspended beginning Q2 2025, removing ~$67M/year of shareholder distributions (10-K 2025-12-31, Liquidity).
• Widening gap between GAAP net loss and Adjusted EBITDA: FY 2025 net loss $356.5M vs Adjusted EBITDA $801.7M; H1 2026 net loss $1,128.8M vs Adjusted EBITDA $356.8M, driven by recurring "non-recurring" impairments and fair-value adjustments (10-K 2025-12-31, Use of Adjusted EBITDA; 10-Q 2026-06-30, Use of Adjusted EBITDA).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue has declined for two consecutive full years: $1,678.1M (2023) → $1,579.5M (2024, -5.8%) → $1,501.4M (2025, -4.9%) (10-K 2025-12-31, Consolidated Statements of Operations). The decline continued in H1 2026: $701.9M vs $761.7M in H1 2025 (-7.8%) (10-Q 2026-06-30, Consolidated Statements of Operations). Operating income swung from $526.9M (2023) to $441.9M (2024) to -$207.4M (2025), the latter including $586.0M of impairments (10-K 2025-12-31, Consolidated Statements of Operations). Net income followed the same path: $224.6M (2023) → $14.5M (2024) → -$356.5M (2025) (10-K 2025-12-31, Consolidated Statements of Operations). In H1 2026, net loss widened to -$1,128.8M from -$435.4M in H1 2025, driven by $597.7M impairments and $457.8M MBI fair-value losses (10-Q 2026-06-30, Consolidated Statements of Operations). Residential data ARPU was essentially flat (+0.6% in 2025, ~0% in H1 2026) while PSUs fell 5-7% annually, confirming volume-driven revenue erosion (10-K 2025-12-31, ARPU; 10-Q 2026-06-30, ARPU).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow peaked at $664.1M in 2024 after $663.2M in 2023, then fell 15.2% to $563.3M in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The decline continued in H1 2026: $239.1M vs $261.3M in H1 2025 (-8.5%) (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Capital expenditures have been stable near $285-286M annually and ~$140M per half-year (10-K 2025-12-31, Capital Expenditures; 10-Q 2026-06-30, Capital Expenditures). Implied free cash flow (operating cash flow minus capex) therefore dropped from ~$378M (2024) to ~$278M (2025) and from ~$122M (H1 2025) to ~$97M (H1 2026). Financing cash outflows increased sharply in 2025 to $410.0M from $136.3M in 2024, driven by higher debt repayments and the dividend suspension (10-K 2025-12-31, Consolidated Statements of Cash Flows). In H1 2026, financing outflows were $124.2M vs $131.4M in H1 2025, with the reduction attributable to the absence of a $17.2M dividend payment (10-Q 2026-06-30, Liquidity).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets contracted from $6,525.9M (2024) to $5,588.4M (2025) and further to $4,622.8M at June 30, 2026 (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). The decline reflects successive impairment charges on franchise agreements ($497.2M then $526.0M) and goodwill ($88.8M then $71.7M), plus equity investment sales ($134.0M proceeds in 2025) and fair-value write-downs. Long-term debt decreased from $3,571.5M to $2,600.4M in 2025 but rebounded to $3,027.1M at June 30, 2026 after a $550M revolver draw to retire the 2026 Notes (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Financing Activity). A $426.0M current MBI Put Option liability appeared at June 30, 2026 (10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Stockholders' equity fell from $1,796.0M (2024) to $1,433.6M (2025) to $326.4M (June 2026), a cumulative 82% decline driven by net losses and other comprehensive losses (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). The company remained in compliance with debt covenants at both period ends (10-K 2025-12-31, Financing Activity; 10-Q 2026-06-30, Financing Activity).

6. Data Gaps

• Full-year 2023 Adjusted EBITDA (non-GAAP) not disclosed in provided filings; only 2024 and 2025 shown.
• Standalone Q1 2026, Q3 2025, Q4 2025, and Q1 2025 income statement, cash flow, and balance sheet details not provided (only Q2 and H1 comparatives in 2026-06-30 10-Q).
• Covenant leverage ratios (Total Net Leverage Ratio, First Lien Net Leverage Ratio) as of 2025-12-31 and 2026-06-30 not explicitly stated in the provided text.
• Detailed breakdown of 2023 revenue by product line to confirm three-year trend consistency.
• Final MBI acquisition closing date, exact put price, and post-closing pro forma balance sheet not yet finalized.
• Quantitative impact of DOCSIS 4.0 deployment and mobile pilot on future capex and revenue not quantified.